Biobadaser Group[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2003	1
2005	1
2006	2
2007	1
2008	1
2022	0

Page 1

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M; BIOBADASER Group. Carmona L, et al. Arthritis Rheum. 2005 Jun;52(6):1766-72. doi: 10.1002/art.21043. Arthritis Rheum. 2005. PMID: 15934089 Free article.

Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

Gómez-Reino JJ, Carmona L, Angel Descalzo M; Biobadaser Group. Gómez-Reino JJ, et al. Arthritis Rheum. 2007 Jun 15;57(5):756-61. doi: 10.1002/art.22768. Arthritis Rheum. 2007. PMID: 17530674 Free article.

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER.

Carmona L, Gómez-Reino JJ; BIOBADASER Group. Carmona L, et al. Arthritis Res Ther. 2006;8(3):R72. doi: 10.1186/ar1941. Epub 2006 Apr 18. Arthritis Res Ther. 2006. PMID: 16620398 Free PMC article.

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period.

Gomez-Reino JJ, Carmona L; BIOBADASER Group. Gomez-Reino JJ, et al. Arthritis Res Ther. 2006;8(1):R29. doi: 10.1186/ar1881. Epub 2006 Jan 6. Arthritis Res Ther. 2006. PMID: 16507128 Free PMC article.

Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience.

Peña-Sagredo JL, Hernández MV, Fernandez-Llanio N, Giménez-Ubeda E, Muñoz-Fernandez S, Ortiz A, Gonzalez-Gay MA, Fariñas MC; Biobadaser group. Peña-Sagredo JL, et al. Clin Exp Rheumatol. 2008 Sep-Oct;26(5):854-9. Clin Exp Rheumatol. 2008. PMID: 19032819

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD; BIOBADASER Group. Gómez-Reino JJ, et al. Arthritis Rheum. 2003 Aug;48(8):2122-7. doi: 10.1002/art.11137. Arthritis Rheum. 2003. PMID: 12905464 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results